⌘K

Login Start Free

Home/Insiders/Satlin Andrew

SA

SEC Insider//CIK 0001722858

Satlin Andrew

CIK 00017228581 companyNEW YORK, NY

Transactions

8

Companies

1

Filings

4

CIK

0001722858

Recent Transactions

8 trades

Award
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2020-02-18+26,754→ 26,754 total
Award
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2020-02-18+33,417→ 33,417 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2020-01-09$26.16/sh−11,573→ 11,338 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2020-01-08+22,911→ 22,911 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2020-01-08−22,911→ 45,824 total
Award
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2019-01-08+94,443→ 94,443 total
Award
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2019-01-08+68,735→ 68,735 total
Award
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2017-11-13+170,500→ 170,500 total

Companies

1

Intra-Cellular Therapies, Inc.
EVP and Chief Medical Officer

Recent Filings

4

Address

C/O INTRA-CELLULAR THERAPIES, INC. 430 EAST 29TH STREET

NEW YORK, NY, 10016

View on SEC.gov